Drug Shortage Report for MYOCHRYSINE
| Report ID | 14864 |
| Drug Identification Number | 01927620 |
| Brand name | MYOCHRYSINE |
| Common or Proper name | Myochrysine |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GOLD SODIUM THIOMALATE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 5 |
| ATC code | M01CB |
| ATC description | SPECIFIC ANTIRHEUMATIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2017-07-07 |
| Actual start date | 2017-07-07 |
| Estimated end date | |
| Actual end date | 2017-08-03 |
| Shortage status | Resolved |
| Updated date | 2017-08-04 |
| Company comments | Manufacturing Delay |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-07-06 | English | Compare |
| v2 | 2017-07-06 | French | Compare |
| v3 | 2017-07-08 | English | Compare |
| v4 | 2017-08-03 | English | Compare |
| v5 | 2017-08-03 | French | Compare |
| v6 | 2017-08-04 | English | Compare |
Showing 1 to 6 of 6